160 related articles for article (PubMed ID: 8648771)
1. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results.
Shinohara K; Connolly JA; Presti JC; Carroll PR
J Urol; 1996 Jul; 156(1):115-20; discussion 120-1. PubMed ID: 8648771
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
Koppie TM; Shinohara K; Grossfeld GD; Presti JC; Carroll PR
J Urol; 1999 Aug; 162(2):427-32. PubMed ID: 10411051
[TBL] [Abstract][Full Text] [Related]
3. Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy.
Bales GT; Williams MJ; Sinner M; Thisted RA; Chodak GW
Urology; 1995 Nov; 46(5):676-80. PubMed ID: 7495120
[TBL] [Abstract][Full Text] [Related]
4. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
Cohen JK; Miller RJ; Rooker GM; Shuman BA
Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
[TBL] [Abstract][Full Text] [Related]
5. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
[TBL] [Abstract][Full Text] [Related]
6. Cryosurgery as a treatment for prostate carcinoma: results and complications.
Wong WS; Chinn DO; Chinn M; Chinn J; Tom WL; Tom WL
Cancer; 1997 Mar; 79(5):963-74. PubMed ID: 9041159
[TBL] [Abstract][Full Text] [Related]
7. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate.
Shuman BA; Cohen JK; Miller RJ; Rooker GM; Olson PR
J Urol; 1997 Feb; 157(2):552-5. PubMed ID: 8996354
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma.
Miller RJ; Cohen JK; Shuman B; Merlotti LA
Cancer; 1996 Apr; 77(8):1510-4. PubMed ID: 8608536
[TBL] [Abstract][Full Text] [Related]
9. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
11. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
Kupelian P; Katcher J; Levin H; Zippe C; Klein E
Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and complications of salvage cryotherapy of the prostate.
Pisters LL; von Eschenbach AC; Scott SM; Swanson DA; Dinney CP; Pettaway CA; Babaian RJ
J Urol; 1997 Mar; 157(3):921-5. PubMed ID: 9072600
[TBL] [Abstract][Full Text] [Related]
13. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
[TBL] [Abstract][Full Text] [Related]
14. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
15. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y
J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
[TBL] [Abstract][Full Text] [Related]
16. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
[TBL] [Abstract][Full Text] [Related]
17. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
18. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
19. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
[TBL] [Abstract][Full Text] [Related]
20. Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy.
Lowe BA; Lieberman SF
J Urol; 1997 Oct; 158(4):1452-6. PubMed ID: 9302141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]